The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
批准号:
10607151
负责人:
Hannah Miles
金额:
$3.63万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2025-03-31
关键词:
5 Alpha-Reductase InhibitorAdrenergic alpha-AntagonistsAdultAffectAgeAgingAgonistAndrogensApoptoticAutomobile DrivingBenign Prostatic HypertrophyBindingBiologicalBiological MarkersBladderChromatographyClinicalComplexDetectionDevelopmentDiagnosisDiseaseDisease ProgressionEarly DiagnosisEstrogen Receptor alphaEstrogen Receptor betaEstrogen ReceptorsEstrogen TherapyEstrogen declineEstrogensEtiologyFibrosisFinancial HardshipFunctional disorderGoalsGrowthHealthcare IndustryHormonesHumanImageInvestigationKidney FailureKnowledgeLabelLigandsLower urinary tractMass Spectrum AnalysisMediationMethodsModelingMolecularMonitorMusObstructionOperative Surgical ProceduresPathogenesisPatientsPeptidesPlayPopulationProcessProliferatingProstateProstaticProtein AnalysisProteinsProteomicsRaloxifeneResearchResolutionRoleRunningSamplingSelective Estrogen Receptor ModulatorsSerumSignal PathwaySignal TransductionSmooth MuscleSpecimenSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStratificationTechniquesTestingTherapeuticTherapeutic InterventionTissuesTranslatingTreatment EfficacyUrinary RetentionUrinationUrineWorkandrogen biosynthesisantagonistbiomarker panelclinically relevantestrogenicexperimental studyhigh throughput analysisimprovedin vivoinsightinstrumentationlower urinary tract symptomsmalemass spectrometric imagingmedicine manmennovelnovel markerpatient populationpharmacologicprecision medicinepreventprotein expressionreceptorreceptor bindingrecurrent infectionreduce symptomssteroid hormonetherapeutic targettreatment strategyurinaryurologic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract
Benign prostatic hyperplasia (BPH) is a disease impacting much of the aging male population, affecting 50% of
men 50 and older, and increasing to 90% of men 80 and older. The etiology of BPH is complex and multifactorial,
though proliferation, smooth muscle dysfunction and fibrosis within the prostate are often considered the largest
contributing factors, in addition to age. Estrogen signaling via receptors (ERs) within the prostate have been
shown to play conflicting roles, with ERα associated with increased proliferation while ERβ with apoptotic
processes. Current BPH therapeutic strategies target androgen biosynthesis without considering that androgens
are regularly converted to estrogenic ligands in the steroid hormone signaling pathway. I hypothesize that
estrogen signaling within the prostate, specifically ERα activity, induces prostatic fibrosis and thus
contributes to the development of lower urinary tract dysfunction (LUTD) and BPH. I aim to evaluate this
hypothesis through the use of mass spectrometry (MS)-based proteomics analyses. With the development of
high resolution and accurate mass instrumentation, MS has become the preferred technique for deep, targeted
and global proteomic profiling investigations. In addition, the development of mass spectrometry imaging (MSI)
allows for high throughput analysis of protein and peptide species in a biological tissue with no prior knowledge,
thus obtaining critical spatial information of hundreds of analytes in a single imaging run. I plan to utilize the high
sensitivity and selectivity of both MSI and traditional chromatography-based LC-MS/MS experiments to reach
the following goals: 1) to determine if ERα agonism in mice promotes prostatic fibrosis and LUTD and 2) to
uncover if loss of ERα function decreases prostatic fibrosis in vivo. Collectively, these aims will both facilitate the
use of MS-based strategies in urologic research and yield novel insights into the complex roles that estrogen
receptor alpha plays within the prostate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文